{"id":27261,"date":"2026-06-06T16:08:38","date_gmt":"2026-06-06T10:38:38","guid":{"rendered":"https:\/\/trending.niftytrader.in\/?p=27261"},"modified":"2026-06-06T16:30:20","modified_gmt":"2026-06-06T11:00:20","slug":"seafood-exports-hit-43pct-antibiotic-rejects","status":"publish","type":"post","link":"https:\/\/www.niftytrader.in\/markets\/seafood-exports-hit-43pct-antibiotic-rejects\/","title":{"rendered":"India’s $8.46B Seafood Exports Hit by 43% Antibiotic Rejections"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

India’s seafood sector hit a record $8.46 billion in exports in FY26, according to MPEDA data released June 1, but the Central Drugs Standard Control Organisation (CDSCO)<\/a> flagged on June 3 that 43% of all shrimp rejections by the US, EU, and Japan in 2025 were caused by banned antibiotic residues chloramphenicol and nitrofurans, more than a year after their formal prohibition under the Drugs and Cosmetics Act of 1940.<\/p>\n

Record Numbers, Then a Red Flag<\/h2>\n

 <\/p>\n

The FY26 performance was undeniably strong. Total shipments crossed 19.72 million metric tonnes valued at \u20b973,890 crore, with growth of 16.13% by volume and 18.4% by value year-on-year. Frozen shrimp drove the bulk of it, \u20b949,037 crore ($5.62 billion), accounting for 66.52% of total dollar earnings.<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n
Metric<\/th>\nFY26 Figure<\/th>\n<\/tr>\n<\/thead>\n
Total Seafood Exports<\/td>\n$8.46 billion \/ \u20b973,890 crore<\/td>\n<\/tr>\n
Total Volume<\/td>\n19.72 million MT<\/td>\n<\/tr>\n
Frozen Shrimp Earnings<\/td>\n$5.62 billion<\/td>\n<\/tr>\n
Frozen Shrimp Volume<\/td>\n7,92,647 MT<\/td>\n<\/tr>\n
Shrimp Share of Dollar Earnings<\/td>\n66.52%<\/td>\n<\/tr>\n
YoY Volume Growth<\/td>\n16.13%<\/td>\n<\/tr>\n
YoY Value Growth (USD)<\/td>\n18.4%<\/td>\n<\/tr>\n
Average Shrimp Unit Value<\/td>\n$4.29\/kg (down 2.31%)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

What didn’t make the headlines was the unit value. Shrimp’s average realisation fell 2.31% to $4.29 per kg, a quiet signal that India is still competing on volume, not premium quality. That’s the exact backdrop against which the antibiotic contamination crisis lands hardest.<\/p>\n

 <\/p>\n

\"\"<\/a><\/p>\n

Where the US Money Actually Went<\/h2>\n

 <\/p>\n

The US remained the top market in value terms at $2.33 billion, but exports declined 14.22% in dollar value and 19.51% in volume. China stepped in as the largest destination by volume, 4,90,369 MT worth $1.61 billion, up 22.7% in value. The EU held third place at $1.59 billion, growing 37.9% in value.<\/p>\n

\n\n\n\n\n\n\n\n
Market<\/th>\nVolume (MT)<\/th>\nValue<\/th>\nYoY Change (Value)<\/th>\n<\/tr>\n<\/thead>\n
United States<\/td>\n2,79,193<\/td>\n$2.33 billion<\/td>\n\u201314.22%<\/td>\n<\/tr>\n
China<\/td>\n4,90,369<\/td>\n$1.61 billion<\/td>\n+22.7%<\/td>\n<\/tr>\n
European Union<\/td>\n2,97,518<\/td>\n$1.59 billion<\/td>\n+37.9%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

The EU rebound is the one that matters most for what follows. It came after a nine-year negotiation and the approval of 102 Indian fishery establishments for EU export access, a hard-won regulatory win that is now directly at risk.<\/p>\n

The Antibiotic Problem, by the Numbers<\/h2>\n

 <\/p>\n

CDSCO’s June 3 letter from the Drugs Controller General (India) directed all state and UT drug controllers to furnish details of inspections, enforcement actions, and implementation measures against the ban on chloramphenicol and nitrofuran drugs. The contamination was traced to over 40 aquaculture farms across four states.<\/p>\n

 <\/p>\n

\n\n\n\n\n\n\n\n\n
State<\/th>\nShare of Implicated Farms<\/th>\n<\/tr>\n<\/thead>\n
Andhra Pradesh<\/td>\n74%<\/td>\n<\/tr>\n
Odisha<\/td>\n13%<\/td>\n<\/tr>\n
West Bengal<\/td>\n8.7%<\/td>\n<\/tr>\n
Gujarat<\/td>\n4.3%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

 <\/p>\n

Separately, Fisheries Minister Rajiv Ranjan Singh disclosed to Parliament that 19 Indian shrimp export consignments were rejected during 2025-26 due to banned antibiotic presence, 7 by the European Union and 12 by the United States. No rejections in the disclosed count were linked to shrimp diseases or pathogens. The contamination is purely a compliance failure.<\/p>\n

 <\/p>\n

Both substances carry zero-tolerance rules in the US, EU and Japan. Chloramphenicol carries aplastic anaemia risk in humans; nitrofuran metabolites persist in tissue and are potentially carcinogenic. The March 11, 2025 notification prohibited the import, manufacture, sale, distribution, and use of both drugs and their formulations in any food-producing animal rearing system with immediate effect. Farms are still using them anyway.<\/p>\n

What the BAP Certification Data Actually Shows<\/h2>\n

 <\/p>\n

This is the detail absent from most Indian coverage. US FDA refusal data shows that 86.2% of shrimp entry lines refused for antibiotics in the first four months of 2026 originated from processors holding Best Aquaculture Practices (BAP) certification, an internationally recognised food safety standard operated by the Global Seafood Alliance, widely used by Indian exporters to signal credibility to premium buyers.<\/p>\n

 <\/p>\n

In March 2026 alone, 5 of 7 antibiotic-related shrimp refusal entry lines at the US FDA involved Indian shipments, contaminated with amoxicillin, chloramphenicol, and\/or nitrofurans, originating from three different Indian companies.<\/p>\n

 <\/p>\n

That is not a fringe compliance failure. If BAP-certified processors are the primary source of rejections, the problem runs deeper than isolated rogue farms, it points to a structural gap between certification and actual on-ground practice.<\/p>\n

 <\/p>\n

\n\n\n\n\n\n\n\n
US FDA Import Alert<\/th>\nTrigger<\/th>\nIndian Companies Listed (2026)<\/th>\n<\/tr>\n<\/thead>\n
IA 16-127<\/td>\nChloramphenicol in all seafood<\/td>\nMultiple (Feb\u2013Mar 2026)<\/td>\n<\/tr>\n
IA 16-129<\/td>\nNitrofurans in seafood products<\/td>\nMultiple (Dec 2024\u2013Apr 2026)<\/td>\n<\/tr>\n
IA 16-124<\/td>\nUnapproved drugs in aquaculture<\/td>\nListed Mar 9, 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

Shipments on these Import Alerts face detention without physical examination, meaning automatic holds at every US port of entry, not just random testing.<\/p>\n

The Government Response: Task Forces and Traceability<\/h2>\n

 <\/p>\n

The fisheries ministry has directed coastal states to establish Antibiotic Task Forces to monitor and penalise breaches across the aquaculture supply chain. The Export Inspection Council (EIC) mandates testing for banned antibiotics as part of export certification checks, and MPEDA supports compliance through pre-harvest testing using ELISA kits and NABL-accredited laboratories.<\/p>\n

 <\/p>\n

MPEDA, the Coastal Aquaculture Authority (CAA) and EIC jointly run the National Residue Control Plan to track antibiotic residues and align Indian supplies with global standards.<\/p>\n

 <\/p>\n

The Department of Fisheries has also released the National Framework on Traceability in Fisheries and Aquaculture 2025, a unified national digital traceability system designed to bridge compliance gaps and meet stringent import regulations from key markets like the EU and US. The framework acknowledges what the CDSCO letter makes plain: India’s current system is fragmented, manual, and inconsistent across states.<\/p>\n

 <\/p>\n

\n\n\n\n\n\n\n\n\n\n\n
Compliance Mechanism<\/th>\nImplementing Body<\/th>\nStatus<\/th>\n<\/tr>\n<\/thead>\n
National Residue Control Plan<\/td>\nMPEDA + CAA + EIC<\/td>\nActive<\/td>\n<\/tr>\n
Pre-harvest Testing (ELISA\/NABL labs)<\/td>\nMPEDA<\/td>\nActive<\/td>\n<\/tr>\n
SHAPHARI Hatchery Certification<\/td>\nMPEDA<\/td>\nActive<\/td>\n<\/tr>\n
Antibiotic Task Forces<\/td>\nCoastal State Govts<\/td>\nOrdered, rollout unconfirmed<\/td>\n<\/tr>\n
National Digital Traceability Framework<\/td>\nDept of Fisheries<\/td>\nLaunched Nov 2025, implementation ongoing<\/td>\n<\/tr>\n
CDSCO State Compliance Reports<\/td>\nState Drug Controllers<\/td>\nDirected June 3, 2026; deadline not disclosed<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

The Value-Addition Contradiction<\/h2>\n

 <\/p>\n

Commerce Minister Piyush Goyal has publicly set a $30 billion seafood export target within five years, 2.5x current levels. Fisheries Minister Singh has called for value addition to exceed 25%, comparable to China. Currently only 12% of India’s fish processing involves meaningful value addition.<\/p>\n

\n\n\n\n\n\n\n\n
Benchmark<\/th>\nCurrent Level<\/th>\nTarget<\/th>\n<\/tr>\n<\/thead>\n
Value Addition (Processing)<\/td>\n~12%<\/td>\n25%+<\/td>\n<\/tr>\n
Seafood Export Target<\/td>\n$8.46 billion (FY26)<\/td>\n$30 billion (5 years)<\/td>\n<\/tr>\n
Shrimp Unit Value<\/td>\n$4.29\/kg (\u20132.31% YoY)<\/td>\n\u2014<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

Moving into ready-to-eat, branded, and nutraceutical categories requires deeper access to precisely those markets, the US, the EU, and Japan, that are now detaining Indian shrimp shipments without physical examination. A 43% antibiotic rejection rate and a premium market growth strategy cannot coexist.<\/p>\n

Read Next: Nazara Technologies Allots 1.82 Crore Warrants, Collects Rs 118.5 Crore Upfront<\/a><\/p>\n

FAQ<\/h2>\n

 <\/p>\n

Q. Which Indian states have the most antibiotic-contaminated shrimp farms?<\/strong><\/h3>\n

 <\/p>\n

Andhra Pradesh leads with 74% of over 40 implicated farms, followed by Odisha (13%), West Bengal (8.7%), and Gujarat (4.3%), per CDSCO’s June 3 directive based on MPEDA data. Andhra Pradesh also accounts for 66% of India’s total shrimp exports; the contamination is concentrated exactly where production volume is highest.<\/p>\n

 <\/p>\n

Q. How many Indian shrimp consignments were actually rejected in 2025-26 for antibiotics?<\/strong><\/h3>\n

 <\/p>\n

Fisheries Minister Rajiv Ranjan Singh disclosed 19 consignment rejections to Parliament, 12 by the US and 7 by the EU. All were antibiotic-related; none were linked to disease or pathogens.<\/p>\n

 <\/p>\n

Q. Has the US FDA already taken action against Indian shrimp exporters?<\/strong><\/h3>\n

 <\/p>\n

Yes. Multiple Indian companies were added to US FDA Import Alerts 16-127 (chloramphenicol) and 16-129 (nitrofurans) between December 2024 and April 2026, triggering detention without physical examination at all US ports. In March 2026 alone, 5 of 7 antibiotic-related shrimp refusals at the FDA were Indian shipments.<\/p>\n

\n

The EU’s next scheduled review of Indian fishery establishment approvals and any RASFF alert response to the CDSCO’s June 3 action will be the clearest test of whether the regulatory trust built over nine years holds, or begins to unwind.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
<\/div>\n
\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
<\/div>\n","protected":false},"excerpt":{"rendered":"

India’s seafood sector hit a record $8.46 billion in exports in FY26, according to MPEDA data released June 1, but the Central Drugs Standard Control Organisation (CDSCO) flagged on June 3 that 43% of all shrimp rejections by the US, EU, and Japan in 2025 were caused by banned antibiotic residues chloramphenicol and nitrofurans, more […]<\/p>\n","protected":false},"author":11,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1362],"tags":[2810,2808,2811,2816,2807,2812,2358,1978,2814,2056,2815,2813,2809],"ppma_author":[1523],"class_list":["post-27261","post","type-post","status-publish","format-standard","has-post-thumbnail","category-finance-and-economy-news","tag-aquaculture","tag-compliance","tag-exportmarket","tag-exportnews","tag-foodexports","tag-foodsafety","tag-globaltrade","tag-indianeconomy","tag-marineexports","tag-marketnews","tag-seafoodexports","tag-shrimpexports","tag-tradenews"]," _eael_post_view_count":0,"authors":[{"term_id":1523,"user_id":11,"is_guest":0,"slug":"nikki","display_name":"Nikki Lodha","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/ae2e265bd56e0e890c866fbaa55d29846ba20cc5372adf666652268816af117e?s=96&d=mm&r=g","first_name":"Nikki","last_name":"Lodha","user_url":"https:\/\/www.niftytrader.in\/markets\/","author_category":"","description":""}],"_links":{"self":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/27261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/comments?post=27261"}],"version-history":[{"count":7,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/27261\/revisions"}],"predecessor-version":[{"id":27273,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/posts\/27261\/revisions\/27273"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/media\/27263"}],"wp:attachment":[{"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/media?parent=27261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/categories?post=27261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/tags?post=27261"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.niftytrader.in\/markets\/wp-json\/wp\/v2\/ppma_author?post=27261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}